Literature DB >> 16219412

Epigenetic control of ovarian function: the emerging role of histone modifications.

Holly A LaVoie1.   

Abstract

The dynamic nature of the ovarian follicle makes it an ideal model to study the coordinated activation and inactivation of genes related to cell growth and differentiation. Much progress has been made in identifying transcription factors that promote the transcription of ovarian genes mediating gonadotropin action and steroidogenesis, but how these factors promote transcription in the context of chromatin is not well understood. Over the past 5 years, epigenetic regulation of ovarian genes through histone modifications has been the focus of an increasing number of studies. Several coactivators and corepressors associated with transcription factors are in fact histone acetyltransferases and histone deacetylases mediating the hyperacetylation and hypoacetylation of histones, respectively. Hyperacetylation of lysine residues in the core histone tails promotes chromatin alterations that favor transcription, whereas hypoacetylation of histones promotes gene silencing or repression. Not only does the acetylation status of the core histones determine whether chromatin remodeling occurs, but histone phosphorylation and methylation may serve equally important roles. For example, the combination of histone H3 phosphorylation and acetylation concertedly favors transcription. In addition, specific lysine methylations (e.g., K9 of histone H3) repress gene expression whereas other methylations promote gene expression. It is most likely the combination of histone modification events that regulate the initiation of transcription. Understanding how ovarian hormones control specific histone modifications will help us understand how follicular cells can switch from active gene pools governing cell proliferation to those gene groups controlling terminal differentiation. Progress in elucidating the ovarian specific regulation of histone modifying enzymes as well as identification of their target gene pools at different stages of the follicular cycle is expected in the next few years.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219412     DOI: 10.1016/j.mce.2005.09.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  15 in total

1.  Metastasis-associated protein 3 (MTA3) regulates G2/M progression in proliferating mouse granulosa cells.

Authors:  Jakub Kwintkiewicz; Elizabeth Padilla-Banks; Wendy N Jefferson; Ilana M Jacobs; Paul A Wade; Carmen J Williams
Journal:  Biol Reprod       Date:  2012-03-08       Impact factor: 4.285

Review 2.  Epigenetic mechanisms in the actions of endocrine-disrupting chemicals: gonadal effects and role in female reproduction.

Authors:  M Uzumcu; A M Zama; E Oruc
Journal:  Reprod Domest Anim       Date:  2012-08       Impact factor: 2.005

Review 3.  Long-term effects of early-life exposure to environmental oestrogens on ovarian function: role of epigenetics.

Authors:  G Cruz; W Foster; A Paredes; K D Yi; M Uzumcu
Journal:  J Neuroendocrinol       Date:  2014-09       Impact factor: 3.627

4.  Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation.

Authors:  Yui Shinojima; Tadashi Terui; Hiroyuki Hara; Makoto Kimura; Jun Igarashi; Xiaofei Wang; Hiroyuki Kawashima; Yujin Kobayashi; Satomi Muroi; Satoshi Hayakawa; Mariko Esumi; Kyoko Fujiwara; Srimoyee Ghosh; Tatsuo Yamamoto; William Held; Hiroki Nagase
Journal:  J Dermatol Sci       Date:  2010-05-20       Impact factor: 4.563

5.  Developmental Programming: Contribution of Epigenetic Enzymes to Antral Follicular Defects in the Sheep Model of PCOS.

Authors:  Xingzi Guo; Muraly Puttabyatappa; Robert C Thompson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

6.  Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor.

Authors:  Jian Qi; You-Qing Zhu; Jun Luo; Wen-Hui Tao
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

7.  Fetal programming of adult Leydig cell function by androgenic effects on stem/progenitor cells.

Authors:  Karen R Kilcoyne; Lee B Smith; Nina Atanassova; Sheila Macpherson; Chris McKinnell; Sander van den Driesche; Matthew S Jobling; Thomas J G Chambers; Karel De Gendt; Guido Verhoeven; Laura O'Hara; Sophie Platts; Luiz Renato de Franca; Nathália L M Lara; Richard A Anderson; Richard M Sharpe
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

Review 8.  Minireview: epigenetic changes in ovarian cancer.

Authors:  Curt Balch; Fang Fang; Daniela E Matei; Tim H-M Huang; Kenneth P Nephew
Journal:  Endocrinology       Date:  2009-07-02       Impact factor: 4.736

Review 9.  Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.

Authors:  Daniela E Matei; Kenneth P Nephew
Journal:  Gynecol Oncol       Date:  2009-10-24       Impact factor: 5.482

10.  CBP-CITED4 is required for luteinizing hormone-triggered target gene expression during ovulation.

Authors:  Yin-Li Zhang; Yan Xia; Chao Yu; JoAnne S Richards; Junping Liu; Heng-Yu Fan
Journal:  Mol Hum Reprod       Date:  2014-05-30       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.